SOD1 and amyotrophic lateral sclerosis: Preclinical studies have demonstrated that CRISPR/Cas9-mediated gene knockdown can repress mutant SOD1 expression, resulting in reduced misfolded SOD1 protein, improved motor function, delayed disease onset, and extended survival in SOD1-ALS mouse models.